Immunogenicity of biotherapeutics: a need for consensus on flexibility of approach
Curr Drug Saf
.
2010 Oct;5(4):272-4.
doi: 10.2174/157488610792245975.
Author
Stewart Barker
PMID:
20925649
DOI:
10.2174/157488610792245975
No abstract available
Publication types
Editorial
Introductory Journal Article
MeSH terms
Antibody Formation
Biological Products / adverse effects*
Biological Products / immunology*
Humans
Practice Guidelines as Topic
Substances
Biological Products